Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae

被引:120
作者
Rozen, Daniel E.
McGee, Lesley
Levin, Bruce R.
Klugman, Keith P.
机构
[1] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Biol, Atlanta, GA 30322 USA
关键词
D O I
10.1128/AAC.01161-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The fitness cost of the genes responsible for resistance to fluoroquinolones in clinical isolates of Streptococcus pneumoniae were estimated in vitro in a common genetic background. Naturally occurring parC, parE, and gyrA loci containing mutations in the quinolone-resistance-determining regions were introduced by transformation into S. pneumoniae strain R6 individually and in combinations. The fitness of these transformants was estimated by pairwise competition experiments with a common R6 strain. On average, single par and gyr mutants responsible for low-level MIC resistance (first-step resistance) impose a fitness burden of approximately 8%. Some of these mutants engender no measurable cost, while one, a parE mutant, reduces the fitness of these bacteria by more than 40%. Most interestingly, the addition of the second par or gyr mutations required for clinically significant, high-MIC fluoroquinolone resistance does not increase the fitness burden imposed by these single genes and can even reduce it. We discuss the implications of these results for the epidemiology of fluoroquinolone resistance and the evolution of acquired resistance in treated patients.
引用
收藏
页码:412 / 416
页数:5
相关论文
共 52 条
[1]  
ADERSSON DI, 1999, CURR OPIN MICROBIOL, V2, P489
[2]   Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern:: Is it time to resight the goalposts? [J].
Ambrose, PG ;
Bast, D ;
Doern, GV ;
Iannini, PB ;
Jones, RN ;
Klugman, KP ;
Low, DE .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) :1554-1556
[3]   The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance [J].
Austin, DJ ;
Kristinsson, KG ;
Anderson, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1152-1156
[4]   A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus:: Evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux [J].
Beyer, R ;
Pestova, E ;
Millichap, JJ ;
Stosor, V ;
Noskin, GA ;
Peterson, LR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :798-801
[5]   Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori [J].
Björkholm, B ;
Sjölund, M ;
Falk, PG ;
Berg, OG ;
Engstrand, L ;
Andersson, DI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) :14607-14612
[6]   A European study on the relationship between antimicrobial use and antimicrobial resistance [J].
Bronzwaer, SLAM ;
Cars, O ;
Buchholz, U ;
Mölstad, S ;
Goettsch, W ;
Veldhuijzen, IK ;
Kool, JL ;
Sprenger, MJW ;
Degener, JE .
EMERGING INFECTIOUS DISEASES, 2002, 8 (03) :278-282
[7]   Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995 [J].
Brueggemann, AB ;
Coffman, SL ;
Rhomberg, P ;
Huynh, H ;
Almer, L ;
Nilius, A ;
Flamm, R ;
Doern, GV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) :680-688
[8]   Modeling epidemics of multidrug-resistant M-tuberculosis of heterogeneous fitness [J].
Cohen, T ;
Murray, M .
NATURE MEDICINE, 2004, 10 (10) :1117-1121
[9]   Seasonal patterns of invasive pneumococcal disease [J].
Dowell, SF ;
Whitney, CG ;
Wright, C ;
Rose, CE ;
Schuchat, A .
EMERGING INFECTIOUS DISEASES, 2003, 9 (05) :573-579
[10]   The mutant selection window and antimicrobial resistance [J].
Drlica, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) :11-17